Oruka Therapeutics, Inc. - Common Stock ORKA 深 滬
已收盤 09-19 16:00:00 美东时间
24.82
-0.560
-2.21%
華盛通- 最 高26.754
- 今 開25.72
- 成交量 7.09万股
- 最 低 24.70
- 昨 收 25.38
- 總市值 8.69亿
- 52周最高 34.524
- 市盈率 靜 --
- 換手率 0.20%
- 52周最低 -0.636
- 委 比 93.76%
- 總股本 3499.86万
- 歷史最高 5922.804
- 量 比 1.00
- 振 幅 8.09%
- 歷史最低 -0.636
- 每 手 1
- 風險率 10.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Innovative Antibody Engineering Positions Oruka Therapeutics for Market Success
Oruka Therapeutics (ORKA) has received a new Buy rating, initiated by TD Cowen ...
09-16 17:45
Oruka Therapeutics Secures $200M to Advance Skin Disease Treatments
Oruka Therapeutics ( ($ORKA) ) just unveiled an update. Oruka Therapeutics, Inc...
09-14 04:28
Oruka Therapeutics announces $200M private financing
Oruka Therapeutics (NASDAQ:ORKA) is looking to raise approximately $200M from a private investment in public equity (PIPE) financing. Oruka is selling 5.6M shares of its common stock at $23 each, 2,43...
09-12 20:08
美股周涨跌榜 | 业绩大放异彩！蔚来周涨逾24%，Q3交付指引超预期；疫苗公司Vaxcyte周飙涨38%
业绩大放异彩！蔚来周涨逾24%，Q3交付指引超预期；安全性比肩辉瑞！疫苗公司Vaxcyte周飙涨38%；FYBR周涨23%，Verizon欲斥现金200亿美元收购>>
09-07 11:41
Oruka Therapeutics Completes Merger with ARCA Biopharma, Begins Trading Under ORKA, Appoints CRISPR CEO as Chairman
Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today announced
09-03 19:06
